Skip to main content

Want a detailed portfolio tracker?

BWAY
NASDAQ
$16.50

Brainsway Ltd (BWAY)

Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
Website: https://www.brainsway.com
68 analysts
Buy
Target: $17.50 (+6.06%)

Market Cap

$440M

PEG Ratio

0.36

Forward P/E

37.45

P/E Ratio

79.88

Price Chart

Valuation
Market Cap$440M
P/E79.88
Forward P/E37.45
PEG0.36
P/S9.63
P/B4.16
Profitability
Total Revenue (TTM)$49M
Gross Profit (TTM)$42M
EBITDA$8.79M
Profit Margin11.6%
Operating Margin9.3%
EPS$0.29
Financial Health
Debt-to-Equity9.6%
Free Cash Flow Yield4.17%
Growth & Risk
Revenue 5Y CAGR+18.20%
Beta (5Y)1.13
Sharpe Ratio2.17